News
-
-
-
PRESS RELEASE
ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows
New findings from the FLOW trial at the ERA Congress show semaglutide improves quality of life in type 2 diabetes and kidney disease patients, with benefits across daily life aspects